The US Army claims that it has discovered a vaccine that protects against all COVID-19 types.
The Walter Reed Army Institute of Research created a 24-sided device that coronavirus protein spikes could be attached to. Fox News reports that the vaccine has passed phase 1 testing. However, researchers are still waiting to compare it to the omicron version.
Researchers obtained a sample in early 2020 and focused their efforts on developing a vaccine to protect against mutations. Two years later, the first results are positive.
The first human phase 1 studies will start in April 2021. Scientists have praised the preliminary findings as promising and plan to release the complete results of phase 1 research once the analysis is complete.
Spike Ferritin Nanoparticle platform (SpFN) vaccine idea suggests that multiple spike proteins may be released in an orderly pattern to generate a “potent, wide response.”
Preclinical results published in Science Translational Medicine indicate that COVID-19 protects against both the original COVID-19 strain and variations of the SARS-CoV-1 virus.
The vaccine’s interaction with those who have been vaccinated before or have had an illness is one of the most fascinating aspects.
Dr. Marty Makary stated to Shannon Bream, Fox News anchor, that WRAIR would work with an unnamed industry partner for a larger deployment. However, that rollout could take up to a year.
